ArticleBriefings in bioinformatics2025
A multi-omics integration framework using multi-label guided learning and multi-scale fusion.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Application of deep learning in crop research: From genomics to phenomics.The plant genome · 2026Review
- Deep chemical structure graph learning deciphers the lipotoxicity code of hypertriglyceridemic pancreatitis.NPJ digital medicine · 2026Article
- Graph designs for deep learning-based multi-omics integration.Briefings in bioinformatics · 2026Review
- Toward trustworthy artificial intelligence in multi-omics: a review of reproducibility, stability, and interpretability.Briefings in bioinformatics · 2026Review
- Metabolic syndrome and a broken heart: trust your gut or risk your heart.American journal of physiology. Heart and circulatory physiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The rapid development of high-throughput sequencing technologies has generated vast amounts of omics data, making multi-omics integration a crucial approach for understanding complex diseases. Despite the introduction of various multi-omics integration methods in recent years, existing approaches still have limitations, primarily in their reliance on manual feature selection, restricted applicability, and inability to comprehensively capture both inter-sample and cross-omics interactions. To address these challenges, we propose mmMOI, an end-to-end multi-omics integration framework that incorporates multi-label guided learning and multi-scale attention fusion. mmMOI directly processes raw high-dimensional omics data without requiring manual feature selection, thereby enhancing model interpretability and eliminating biases introduced by feature preselection. First, we introduce a multi-label guided multi-view graph neural network, which enables the model to adaptively learn omics data representations across different datasets, thereby improving generalizability and stability. Second, we design a multi-scale attention fusion network, which integrates global attention and local attention. This dual-attention mechanism allows mmMOI to more accurately integrate multi-omics data, enhance cross-omics feature representations, and improve classification performance. Experimental results demonstrate that mmMOI significantly outperforms state-of-the-art methods in classification tasks, exhibiting high stability and adaptability across diverse biological contexts and sequencing technologies. Additionally, mmMOI successfully identifies key disease-associated biomarkers, further enhancing its biological interpretability and practical relevance. The source code, datasets, and detailed hyperparameter configurations for mmMOI are available at https://github.com/mlcb-jlu/mmMOI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.